频繁失去CACNA1C与非小细胞肺癌的预后不佳有关
Saanvi Dasgupta1, Sapthala L Galappaththi2,3, Rajarshi Banerjee2,3
1University of Alabama at Birmingham, Birmingham, Alabama, USA.
概括
由遗传变化和促进物甲基化驱动的CACNA1C表达的丧失与晚期非小细胞肺癌 (NSCLC) 阶段和患者生存率低下有关. 这表明CACNA1C的改变可能是肺腺癌 (LUAD) 的早期事件.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC),包括肺腺癌 (LUAD) 和状细胞癌 (LUSC),通常呈现于晚期,预后不佳.
- 编码通道子单元的CACNA1C基因尚未在NSCLC中得到广泛研究.
研究的目的:
- 调查CACNA1C变化的作用,包括拷贝数变化,mRNA表达,促进物甲基化和突变,在LUAD和LUSC的发展和进展中.
- 评估CACNA1C变化的关联与NSCLC的临床参数和患者存活率.
主要方法:
- 对NSCLC瘤和活检进行高分辨率SNP阵列分析,以识别复制中性异构性损失 (LOH).
- 使用癌症基因组图谱 (TCGA) 分析瘤与正常组织中的CACNA1CmRNA表达的转录基因分析.
- 在NSCLC队列中分析CACNA1C促进体甲基化和突变状态.
- 在NSCLC瘤和淋巴结转移的独立队列中验证CACNA1C蛋白表达.
主要成果:
- 与正常组织相比,在LUAD和LUSC瘤中观察到频繁的副本中性LOH和CACNA1C的mRNA表达减少.
- 对CACNA1CmRNA表达的丧失和促进剂高甲基化增加显着与晚期,更高等级,淋巴结转移,P53突变和较差的存活率有关.
- 确定了CACNA1C突变,并与免疫功能调节有关.
- 在初级瘤和淋巴结转移中证实了CACNA1C蛋白表达的丧失,在LUAD中作为早期事件出现.
结论:
- 在CACNA1C的变化,包括LOH,减少表达,高甲基化和突变,在NSCLC中很常见.
- CACNA1C下调与瘤的攻击性特征和不良结果有关,突出其作为预后标记物的潜力.
- CACNA1C表达的丧失可能代表LUAD病变的早期事件,这表明它对生物标志物和治疗开发的有用性.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
03:14Notch Signaling Pathway
6.7K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793